News & Events

You are here

Presenting at this year’s Accelerating Clinical Trials in Asia 2017, Novotech CRO Executive Director Dr Yooni Kim presented an overview of recent regulatory change in Asia and discussed its resulting impact on clinical trial management and patient recruitment. 

30/12/16

Novotech Update: Novotech presents to Chinese biotechs on 3 key benefits of early stage clinical trials in Australia

Novotech presented to a number of biotechnology companies based at China’s SuZhou BioBay industrial...

20/12/16

Novotech recognised as Asia Pacific growth leader by Frost & Sullivan research analysts

Sydney, Australia: Leading Asia Pacific CRO Novotech has won the Clinical Research Organisation (CRO) Growth Excellence Leadership award in...

02/12/16

Novotech announces transition of CEO role

Novotech announces transition of CEO role from Alek Safarian to John Moller, effective 23rd January 2017. Currently based in Novotech’s Singapore office, Dr Moller joined Novotech as Chief Operating Officer, Asia, in January 2014 and has overseen...

02/11/16

Novotech Update: Novotech and Deloitte Launch U.S. Biotech Briefings about 60% Savings for Early Phase Clinical Trials in Australia

Sydney, Australia – October 27, 2016: In an industry first Novotech and Deloitte have teamed up to brief U.S. CFOs of early stage companies about Australian tax breaks for early phase clinical trials. 

New research from...

31/08/16

Download Whitepaper - Australia: Preferred Destination for Early Phase Clinical Trials (A Frost and Sullivan White Paper)

 

Click here to download the Frost and Sullivan whitepaper to learn more about the benefits of running early phase trials in Australia.

Click...

18/07/16

Video Recording: Australia: Preferred Destination for Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by Novotech, Australia’s...

26/05/16

Novotech and Frost & Sullivan Present New Data at DIA China on Australia’s Edge in Early Phase Clinical Trials

BEIJING, CHINA - 18 May 2016 | Frost & Sullivan today presented highlights from new research into why Australia is a hub for early phase clinical trials (DIA China, Beijing, May 18, 2016).  The study was supported by...

26/05/16

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Worldwide, there were an estimated 14.1 million new cancer cases in 2012 (American Cancer Society). Almost half of these occur in Asia with almost one quarter of the global burden in China. The top three cancers in women are breast, lung, and...

25/02/16

Webinar - Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors

Governments in Asian countries increasingly view biomedical/life sciences industry as a key segment for future economic growth. Substantial financial support has been granted to this segment resulting in improved clinical research infrastructure...

08/01/16

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

 

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

07 January, 2016: Join industry experts from Novotech...

Pages